• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献>>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

Paraptosis:a non-classical paradigm of cell death for cancer therapy

摘要Due to the sustained proliferative potential of cancer cells,inducing cell death is a potential strategy for cancer therapy.Paraptosis is a mode of cell death characterized by endoplasmic reticulum(ER)and/or mitochondrial swelling and cytoplasmic vacuolization,which is less investigated.Considerable evidence shows that paraptosis can be triggered by various chemical compounds,particularly in cancer cells,thus highlighting the potential application of this non-classical mode of cell death in cancer therapy.Despite these findings,there remain significant gaps in our understanding of the role of paraptosis in cancer.In this review,we summarize the current knowledge on chemical compound-induced paraptosis.The ER and mitochondria are the two major responding organelles in chemical compound-induced paraptosis,which can be triggered by the reduction of protein degradation,disruption of sulfhydryl homeostasis,overload of mitochondrial Ca2+,and increased generation of reactive oxygen species.We also discuss the stumbling blocks to the development of this field and the direction for further research.The rational use of paraptosis might help us develop a new paradigm for cancer therapy.

更多
广告
作者 Chun-cao Xu [1] Yi-fan Lin [2] Mu-yang Huang [1] Xiao-lei Zhang [3] Pei Wang [4] Ming-qing Huang [2] Jin-jian Lu [5] 学术成果认领
作者单位 State Key Laboratory of Quality Research in Chinese Medicine,Institute of Chinese Medical Sciences,University of Macau,Macao,China [1] College of Pharmacy,Fujian University of Traditional Chinese Medicine,Fuzhou 350122,China [2] National-Local Joint Engineering Laboratory of Druggability and New Drug Evaluation,Guangdong Key Laboratory of Chiral Molecule and Drug Discovery,School of Pharmaceutical Sciences,Sun Yat-Sen University,Guangzhou 510080,China [3] Department of Pharmacology,School of Pharmacy,Naval Medical University/Second Military Medical University,Shanghai 200433,China [4] State Key Laboratory of Quality Research in Chinese Medicine,Institute of Chinese Medical Sciences,University of Macau,Macao,China;Department of Pharmaceutical Sciences,Faculty of Health Sciences,University of Macau,Macao,China;MoE Frontiers Science Center for Precision Oncology,University of Macau,Macao,China;Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research,University of Macau,Macao,China;Zhuhai UM Science & Technology Research Institute,Zhuhai 519000,China [5]
栏目名称
DOI 10.1038/s41401-023-01159-7
发布时间 2024-03-19
提交
  • 浏览0
  • 下载0
中国药理学报(英文版)

中国药理学报(英文版)

2024年45卷2期

223-237页

SCIMEDLINEISTICCSCDCABP

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷